S&P 500
5,940.46
-0.4%
-23.14
DJI
42,677.24
-0.3%
-114.83
NASDAQ
$19,142.71
-0.4%
-$72.75
Bitcoin
106,415.00
+0.9%
+960.86
AAPL
$206.73
-1.0%
-$2.05
AMZN
$204.08
-1.0%
-$2.08
GOOG
$165.14
-1.6%
-$2.73
META
$636.43
-0.6%
-$4.00
MSFT
$457.90
-0.2%
-$0.97
NVDA
$134.22
-1.0%
-$1.34
TSLA
$343.52
+0.4%
+$1.43
CRISPR Therapeutics (NASDAQ: CRSP)
$39.27
(1.5%)
$0.59
Price as of May 20, 2025, 3:58 p.m. ET
CRISPR Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
CRISPR Therapeutics Company Info
CRISPR Therapeutics is a biotech company using gene therapy to try to correct genetic mutations to treat and cure diseases.
News & Analysis
The Fool has written over 400 articles on CRISPR Therapeutics.
Featured Article
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?
Cory Renauer | May 20, 2025
Featured Article
Prediction: This Beaten-Down Stock Could Double in The Next 5 Years
Prosper Junior Bakiny | May 18, 2025
Are Investors Making a Big Mistake Dumping Shares of CRISPR Therapeutics?
David Jagielski | May 14, 2025
2 Biotech Stocks That Are Screaming Buys in May
Adria Cimino | May 13, 2025
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
Justin Pope | May 12, 2025
The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline.
3 Magnificent Stocks That Could Double or More by 2030
Keith Speights, David Jagielski, and Prosper Junior Bakiny | Apr 12, 2025
Could CRISPR Therapeutics Become the Next Vertex Pharmaceuticals?
Adria Cimino | Apr 11, 2025
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Prosper Junior Bakiny | Apr 7, 2025
Valuation
Podcast Episodes
"The Era of the Gene-Edited Human Is Here"
An investor's look.
Chris Hill | Sep 19, 2022
Breaking Down CRISPR Technology
What investors need to know.
Karl Thiel | Sep 28, 2021
Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?
Plus, how gene-editing company CRISPR Therapeutics just took a big step forward.
Todd Campbell | Nov 22, 2019
Did China’s “Designer Babies” Just Open Pandora’s Box?
What will this mean for healthcare and for the future of society?
Motley Fool Staff | Dec 21, 2018
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.